Digital AI technology: A game-changer for rare disease diagnosis AI technology isn’t designed to replace clinicians - its function is to help them.
Digital DTx and the case for fit-for-purpose evidentiary standard DTx deliver evidence-based therapeutic interventions driven by high-quality software programs
Digital The connected care horizon in 2023 Some connected care trends expected include digital therapeutics & remote patient monitoring.
Digital Leave no one behind: Digital user research in rare disease Digital solutions have the potential to bridge care gaps for rare disease patients.
Digital Health Innovators – Nigel Brokenshire At the HealthTech X Digitisation of Pharma summit in London in February, pharmaphorum editor-in-chief Jonah Comstock grabbed Nigel Brokenshire, director of UK digital for Bayer, for a quick intervi
Digital Digital measures and pre-competitive collaborations Digital measures from a patient’s home and known environments offer greater health insights.
News Astellas pays $285m for Audax cancer drug, and other deals Astellas takes an option on a cancer immunotherapy developed by Audax for up to $1.34bn, with Gilead and Teva also adding to their pipelines.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
